查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614322

胎兒酒精頻譜障礙治療市場：按類型、治療類型、最終用戶分類 - 全球預測 2025-2030 年

Fetal Alcohol Spectrum Disorder Treatment Market by Type, Treatment Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年胎兒酒精頻譜障礙治療市場價值為37013萬美元，預計2024年將達到38775萬美元，複合年成長率為4.91%，2030年將達到51804萬美元，預計將達到1000萬美元。

胎兒酒精頻譜障礙（FASD）是一種由產前酒精暴露引起的嚴重發展障礙。 FASD 表現為頻譜身體、行為和認知障礙。解決 FASD 的需要包括早期診斷、有效的干涉策略和全面的管理計劃，以改善從嬰幼兒到成人的不同年齡層的患者治療結果並降低終身醫療費用。治療範圍包括多學科方法，其中包括醫療管理、行為治療、教育支持和社會服務，關鍵最終用戶包括醫療保健提供者、治療師和看護者。該市場的成長是由人們對該疾病的認知不斷提高、患病率上升以及診斷技術的進步所推動的。此外，旨在減少懷孕期間飲酒的政府措施和政策框架正在推動市場的進一步成長。然而，挑戰依然存在，包括社會恥辱、診斷不足以及延遲干預的症狀複雜性。醫療保健系統的財務限制也是一個主要障礙。機會包括擴大公眾意識提升宣傳活動、改進診斷方法以及促進醫療機構和研究中心之間的合作以開發創新治療方法。投資遠端醫療解決方案和數位平台也是一個潛在的成長槓桿，特別是在偏遠和服務不足的地區。創新研究領域可以集中於遺傳和神經科學研究，以更好地了解疾病的病因並開發標靶治療。胎兒酒精譜系障礙 (FASD) 治療市場是既定實踐和新興解決方案的結合體，但克服障礙需要強力的跨學科合作、持續的研究資助和政策計劃。這個市場的複雜性、醫療保健、社會行為和政策制定相互交織，為尋求在 FASD 治療方面取得重大進展的公司帶來了充滿挑戰但充滿希望的前景。

主要市場統計
基準年[2023] 37013萬美元
預計年份 [2024] 3.8775億美元
預測年份 [2030] 51804萬美元
複合年成長率（%） 4.91%

市場動態：快速發展的胎兒酒精頻譜障礙治療市場的關鍵市場洞察

胎兒酒精頻譜障礙治療市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球胎兒酒精頻譜障礙 (FASD) 盛行率不斷上升
    • 診斷技術和意識計劃的進步
    • 研究與開發的監管支持
  • 市場限制因素
    • 診斷和標準化的挑戰
  • 市場機會
    • 制定新的治療通訊協定和指南
    • 推出支持政策和資助模式
  • 市場挑戰
    • 產品開發和製造的複雜性

波特五力策略工具引領胎兒酒精頻譜障礙治療市場

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解胎兒酒精頻譜障礙治療市場的外在影響

外部宏觀環境因素在塑造胎兒酒精頻譜障礙治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解胎兒酒精頻譜障礙治療市場的競爭狀況

胎兒酒精頻譜障礙治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣胎兒酒精頻譜障礙治療市場供應商的績效評估

FPNV 定位矩陣是評估胎兒酒精頻譜疾病治療市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃胎兒酒精頻譜障礙治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對胎兒酒精頻譜障礙治療市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球胎兒酒精綜合症（FASD）盛行率不斷上升
      • 診斷技術和意識計劃的進步
      • 研究與開發的監管支持
    • 抑制因素
      • 診斷和標準化的挑戰
    • 機會
      • 制定新的治療通訊協定和指南
      • 推出支持政策和資助模式
    • 任務
      • 產品開發和製造的複雜性
  • 市場區隔分析
    • 類型：嚴重胎兒酒精症候群（FAS），導致身體和精神出生缺陷
    • 最終用戶：臨床偏好作為 FASD 的早期篩檢和診斷點
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章胎兒酒精頻譜障礙治療市場：依類型

  • 酒精相關出生缺陷
  • 酒精相關的神經發育障礙
  • 胎兒酒精綜合症

第7章依治療類型分類的胎兒酒精頻譜障礙治療市場

  • 行為/教育治療
  • 藥物治療

第8章胎兒酒精頻譜障礙治療市場：依最終使用者分類

  • 診所
  • 醫院

第9章美洲胎兒酒精頻譜障礙治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區胎兒酒精頻譜障礙治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲胎兒酒精頻譜障礙治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 加強紐西蘭針對胎兒酒精綜合症的努力和支持
    • 加強胎兒酒精症候群的防範：加拿大政府資助的 CAHS主導的評估
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Amneal Pharmaceuticals Inc.
  • Cipla Ltd.
  • Drukst Biotech Pvt. Ltd.
  • Eli Lilly and Company
  • Elite Pharma Pvt. Ltd.
  • Eris Lifesciences Ltd.
  • GlaxoSmithKline PLC
  • Intas Pharmaceutical Ltd.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Psychotropics India Ltd.
  • RPG Life Sciences Ltd.
  • SP Pharmaceuticals
  • Wens Remedies Pvt. Ltd.
Product Code: MRR-4D00F1312C82

The Fetal Alcohol Spectrum Disorder Treatment Market was valued at USD 370.13 million in 2023, expected to reach USD 387.75 million in 2024, and is projected to grow at a CAGR of 4.91%, to USD 518.04 million by 2030.

Fetal Alcohol Spectrum Disorder (FASD) stands as a critical developmental condition caused by prenatal alcohol exposure. It manifests in a spectrum of physical, behavioral, and cognitive disabilities. The necessity for addressing FASD includes early diagnosis, effective intervention strategies, and comprehensive management plans to improve patient outcomes and reduce lifelong care costs, emphasizing its applicability across diverse age groups from infants to adults. The treatment scope involves multidisciplinary approaches incorporating medical management, behavioral therapy, educational support, and social services, with figures such as healthcare providers, therapists, and caregivers as the pivotal end-users. The market's growth is driven by increased awareness about the condition, rising incidence rates, and advancements in diagnostic technologies. Additionally, government initiatives and policy frameworks aimed at reducing alcohol consumption during pregnancy foster further market growth. However, challenges persist, such as societal stigma, underdiagnosis, and the complexity of symptoms that can delay intervention. Financial constraints in healthcare systems can also pose significant hurdles. Opportunities lie in expanding public awareness campaigns, enhancing diagnostic methods, and fostering collaborations between healthcare institutions and research centers to develop innovative therapies. Investment in telehealth solutions and digital platforms is another potential growth lever, especially in remote or underserved areas. Innovative research areas could focus on genetic and neuroscientific studies to better understand the disorder's etiology and development of targeted therapies. While the FASD treatment market displays a mix of established practices and emerging solutions, it requires robust interdisciplinary collaboration, continuous funding for research, and policy advocacy to overcome its barriers. The nature of this market is complex, intertwining healthcare, societal behaviors, and policy-making, posing a challenging yet promising landscape for businesses aiming to make impactful advancements in FASD treatment.

KEY MARKET STATISTICS
Base Year [2023] USD 370.13 million
Estimated Year [2024] USD 387.75 million
Forecast Year [2030] USD 518.04 million
CAGR (%) 4.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fetal Alcohol Spectrum Disorder Treatment Market

The Fetal Alcohol Spectrum Disorder Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing global prevalence of fetal alcohol spectrum disorders (FASD)
    • Advancements in diagnostic techniques and awareness programs
    • Support from regulatory bodies for research and development
  • Market Restraints
    • Challenges in diagnosis and standardization
  • Market Opportunities
    • Development of New Treatment Protocols and Guidelines
    • Initiation of supportive policies and funding models
  • Market Challenges
    • Complexities in product development and manufacturing

Porter's Five Forces: A Strategic Tool for Navigating the Fetal Alcohol Spectrum Disorder Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fetal Alcohol Spectrum Disorder Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fetal Alcohol Spectrum Disorder Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fetal Alcohol Spectrum Disorder Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fetal Alcohol Spectrum Disorder Treatment Market

A detailed market share analysis in the Fetal Alcohol Spectrum Disorder Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fetal Alcohol Spectrum Disorder Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fetal Alcohol Spectrum Disorder Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fetal Alcohol Spectrum Disorder Treatment Market

A strategic analysis of the Fetal Alcohol Spectrum Disorder Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fetal Alcohol Spectrum Disorder Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amneal Pharmaceuticals Inc., Cipla Ltd., Drukst Biotech Pvt. Ltd., Eli Lilly and Company, Elite Pharma Pvt. Ltd., Eris Lifesciences Ltd., GlaxoSmithKline PLC, Intas Pharmaceutical Ltd., Merck & Co. Inc., Pfizer Inc., Psychotropics India Ltd., RPG Life Sciences Ltd., SP Pharmaceuticals, and Wens Remedies Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Fetal Alcohol Spectrum Disorder Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Alcohol-Related Birth Defects, Alcohol-Related Neurodevelopmental Disorder, and Fetal Alcohol Syndrome.
  • Based on Treatment Type, market is studied across Behavior & Education Therapy and Medication.
  • Based on End-User, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing global prevalence of fetal alcohol spectrum disorders (FASD)
      • 5.1.1.2. Advancements in diagnostic techniques and awareness programs
      • 5.1.1.3. Support from regulatory bodies for research and development
    • 5.1.2. Restraints
      • 5.1.2.1. Challenges in diagnosis and standardization
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of New Treatment Protocols and Guidelines
      • 5.1.3.2. Initiation of supportive policies and funding models
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in product development and manufacturing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: High severity of fetal alcohol syndrome (FAS) causing physical and mental birth defect
    • 5.2.2. End-User: Preferences for clinics as early screening and diagnosis point for FASD
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fetal Alcohol Spectrum Disorder Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Alcohol-Related Birth Defects
  • 6.3. Alcohol-Related Neurodevelopmental Disorder
  • 6.4. Fetal Alcohol Syndrome

7. Fetal Alcohol Spectrum Disorder Treatment Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Behavior & Education Therapy
  • 7.3. Medication

8. Fetal Alcohol Spectrum Disorder Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Fetal Alcohol Spectrum Disorder Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Fetal Alcohol Spectrum Disorder Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Fetal Alcohol Spectrum Disorder Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Enhancing Fetal Alcohol Spectrum Disorder Initiatives and Support in New Zealand
    • 12.3.2. Enhancing Fetal Alcohol Spectrum Disorder Strategies: A CAHS-Led Assessment Funded by Canadian Government
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Amneal Pharmaceuticals Inc.
  • 3. Cipla Ltd.
  • 4. Drukst Biotech Pvt. Ltd.
  • 5. Eli Lilly and Company
  • 6. Elite Pharma Pvt. Ltd.
  • 7. Eris Lifesciences Ltd.
  • 8. GlaxoSmithKline PLC
  • 9. Intas Pharmaceutical Ltd.
  • 10. Merck & Co. Inc.
  • 11. Pfizer Inc.
  • 12. Psychotropics India Ltd.
  • 13. RPG Life Sciences Ltd.
  • 14. SP Pharmaceuticals
  • 15. Wens Remedies Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED BIRTH DEFECTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY ALCOHOL-RELATED NEURODEVELOPMENTAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY FETAL ALCOHOL SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY BEHAVIOR & EDUCATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 145. FETAL ALCOHOL SPECTRUM DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023